Gregory A. Otterson, MD

home / authors / gregory-a-otterson-md

Articles

Dr. Otterson on the Utility of Immunotherapy in NSCLC

Dr. Otterson on the Utility of Immunotherapy in NSCLC

Gregory A. Otterson, MD
May 28th 2020

Gregory A. Otterson, MD, discusses data examining immunotherapy alone versus in combination in non–small cell lung cancer.

Read More

Dr. Otterson on When to Start Immunotherapy in NSCLC

Dr. Otterson on When to Start Immunotherapy in NSCLC

Gregory A. Otterson, MD
April 7th 2020

Gregory A. Otterson, MD, discusses when to start treatment with immunotherapy in patients with non–small cell lung cancer.

Read More

Dr. Otterson on Targetable Biomarkers in Lung Cancer

Dr. Otterson on Targetable Biomarkers in Lung Cancer

Gregory A. Otterson, MD
March 20th 2020

Gregory A. Otterson, MD, discusses targetable biomarkers in non–small cell lung cancer.

Read More

Latest Updated Articles

Sarwish Rafiq, PhD
Published: July 9th 2024 | Updated: July 10th 2024
Dr Rafiq on Novel Strategies for CAR T-Cell Engineering in Solid Tumors
Jens Hoeppner, FAChirg, FACS, MD
Published: June 2nd 2024 | Updated: June 3rd 2024
Perioperative Chemotherapy Prolongs OS vs Neoadjuvant Chemoradiation in Esophageal Cancer
Julia Rotow, MD, clinical director, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; assistant professor, medicine, Harvard Medical School
Published: July 25th 2024 | Updated: July 27th 2024
Dr Rotow on the Impact of Biomarker Testing on NSCLC Treatment Outcomes
Joshua K. Sabari, MD, assistant professor, Department of Medicine, New York University Grossman School of Medicine; director, High Reliability Organization Initiatives, Perlmutter Cancer Center
Published: July 25th 2024 | Updated: July 27th 2024
Dr Sabari on Barriers to Biomarker Testing in NSCLC
5 KOLs are featured in this series.
Published: July 18th 2024 | Updated: July 27th 2024
Treatment Considerations and Patient Selection for CAR T-cell Therapy in R/R ALL
5 KOLs are featured in this series.
Published: July 18th 2024 | Updated: July 27th 2024
Expert Insights on ZUMA-3 Data Updates: 4-Year Follow-up and Real World Data